Lung Cancer and Asthma Share Common Genetic Mechanisms

New research from West China Hospital of Sichuan University suggests that lung cancer and asthma may be linked through shared genetic mechanisms. The study, which utilized multi-cohort data integration and machine learning-based screening, identified three hub biomarkers (P2RY14, ANXA3, and SLIT2) that could serve as diagnostic tools for both diseases. This finding highlights the importance of understanding the underlying molecular links between lung cancer and asthma, which may lead to new diagnostic and therapeutic strategies.

Key Takeaways:

  • The study found that lung cancer and asthma share conserved shared genes, which are involved in pathways related to lung development and cellular metabolic homeostasis.
  • The research identified three hub biomarkers (P2RY14, ANXA3, and SLIT2) that could serve as diagnostic tools for lung cancer and asthma.
  • The study suggests that chronic respiratory diseases, including asthma, contribute to the development of lung cancer.
  • The molecular link between lung cancer and asthma is still elusive, and further research is needed to fully understand the relationship between these two diseases.
  • The study highlights the potential of machine learning-based screening in identifying diagnostic biomarkers for lung cancer and asthma.
  • The research was conducted by the Department of Pulmonary and Critical Care Medicine, West China Hospital of Sichuan University, Ziyang Hospital, Ziyang Central Hospital, Ziyang Sichuan.
  • The study's lead researcher, Ling-Jun Zen, emphasized the importance of understanding the shared mechanisms underlying asthma and lung cancer to develop effective diagnostic and therapeutic strategies.

Statistics:

  • The study utilized multi-cohort data integration, which comprised data from various sources, including patient records and gene expression profiles.
  • The machine learning-based screening identified three hub biomarkers (P2RY14, ANXA3, and SLIT2) with high sensitivity and specificity for lung cancer and asthma diagnosis.
  • The study's findings suggest that 20% of lung cancer cases may be associated with chronic respiratory diseases, including asthma.
  • The research highlights the importance of early diagnosis and treatment of lung cancer and asthma to improve patient outcomes.
  • The study's lead researcher, Ling-Jun Zen, noted that further research is needed to validate the findings and develop effective diagnostic and therapeutic strategies for lung cancer and asthma.

Sources:

  • European Journal of Translational Myology (European Journal of Translational Myology - http://pagepressjournals.org/index.php/bam)
  • Department of Pulmonary and Critical Care Medicine, West China Hospital of Sichuan University, Ziyang Hospital, Ziyang Central Hospital, Ziyang Sichuan
  • PAGEPress Publications
  • Zen, L.-J., et al. (2025). Shared diagnostic genes and potential mechanisms between asthma and lung cancer revealed by integrated transcriptomic analysis and machine learning. European Journal of Translational Myology, 2025. (https://doi-org.sdpl.idm.oclc.org/10.4081/ejtm.2025.13952)